共查询到19条相似文献,搜索用时 171 毫秒
1.
目的 观察瘤体分区缝扎硬化治疗颌面部血管瘤的疗效及不良反应。方法 采用瘤体周围及分区交叉缝扎加瘤腔内注射平阳霉素的方法,治疗颌面部海绵状血管瘤126例。平阳霉素术后可重复注射1~6次。结果 随访观察6-36个月,治愈98例,基本治愈26例,有效2例,无无效病例。临床治愈率(包括治愈和基本治愈)为98.4%。结论 分区缝扎硬化治疗海绵状血管瘤操作简便、安全可靠,治愈率高,特别对于唇部、舌前部、颊部易于阻断血流处治疗效果好,具有较好的治疗应用价值。 相似文献
2.
平阳霉素治疗小儿海绵状血管瘤的疗效分析 总被引:1,自引:0,他引:1
目的:评价平阳霉素瘤内注射治疗小儿海绵状血管瘤的临床疗效。方法:回顾性分析234例海绵状血管瘤常规瘤体内注射平阳霉素(注射次数1次-6次)后的临床资料。结果:经过3年随访,治愈168例,基本治愈12例,好转45例,无效9例。总有效率96.15%。结论:平阳霉素瘤内注射治疗海绵状血管瘤疗效高,疗程短,是一种简便、安全的有效方法。 相似文献
3.
4.
三种不同方法治疗儿童混合性皮肤血管瘤的疗效观察 总被引:1,自引:0,他引:1
目的:观察应用激素、90Sr皮肤敷贴器或/加药物介入法治疗儿童混合性皮肤血管瘤的临床疗效.方法:对200例儿童混合性皮肤血管瘤的患者,分别采用激素、90Sr皮肤敷贴或/加药物介入法治疗.混合性血管瘤68例采用90Sr皮肤敷贴治疗,根据年龄大小和治疗反应决定个体化剂量;56例混合性血管瘤采用口服强的松激素治疗;混合性血管瘤76例先行平阳霉素瘤体内注射,待深部瘤体消退后,浅表性表皮病变再行β射线敷贴治疗.结果:β射线敷贴治疗儿童混合性血管瘤治愈率为57.35%,有效率为80.88%;β射线敷贴器加平阳霉素注射治疗儿童混合性血管瘤治愈率为81.58%,有效率为94.74%;而单纯激素治疗混合性血管瘤治愈率为30.36%,有效率为64.29%.结果表明采用90Sr皮肤敷贴器或/和平阳霉素治疗儿童血管瘤的方法,其疗效明显优于单纯激素治疗.两组疗效比较有非常显著差异(P<0.01).结论:90Sr皮肤敷贴器或/加平阳霉素药物介入疗法是治疗儿童皮肤混合性血管瘤较为有效的方法. 相似文献
5.
目的:观察应用激素、90Sr皮肤敷贴器或/加药物介入法治疗儿童混合性皮肤血管瘤的临床疗效.方法:对200例儿童混合性皮肤血管瘤的患者,分别采用激素、90Sr皮肤敷贴或/加药物介入法治疗.混合性血管瘤68例采用90Sr皮肤敷贴治疗,根据年龄大小和治疗反应决定个体化剂量;56例混合性血管瘤采用口服强的松激素治疗;混合性血管瘤76例先行平阳霉素瘤体内注射,待深部瘤体消退后,浅表性表皮病变再行β射线敷贴治疗.结果:β射线敷贴治疗儿童混合性血管瘤治愈率为57.35%,有效率为80.88%;β射线敷贴器加平阳霉素注射治疗儿童混合性血管瘤治愈率为81.58%,有效率为94.74%;而单纯激素治疗混合性血管瘤治愈率为30.36%,有效率为64.29%.结果表明采用90Sr皮肤敷贴器或/和平阳霉素治疗儿童血管瘤的方法,其疗效明显优于单纯激素治疗.两组疗效比较有非常显著差异(P〈0.01).结论:90Sr皮肤敷贴器或/加平阳霉素药物介入疗法是治疗儿童皮肤混合性血管瘤较为有效的方法. 相似文献
6.
目的 观察瘤体分区缝扎硬化治疗颌面部血管瘤的疗效及不良反应。方法 采用瘤体周围及分区交叉缝扎加瘤腔内注射平阳霉素的方法,治疗颌面部海绵状血管瘤12 6例。平阳霉素术后可重复注射1~6次。结果 随访观察6~3 6个月,治愈98例,基本治愈2 6例,有效2例,无无效病例。临床治愈率(包括治愈和基本治愈)为98 4%。结论 分区缝扎硬化治疗海绵状血管瘤操作简便、安全可靠,治愈率高,特别对于唇部、舌前部、颊部易于阻断血流处治疗效果好,具有较好的治疗应用价值。 相似文献
7.
目的 评价90Sr敷贴+平阳霉素治疗皮肤血管瘤的治疗效果。方法 皮肤血管瘤218例,瘤体243个(单纯性血管瘤108个,海绵状血管瘤74个,混合性血管瘤61个 ); 随机分为两组:90Sr敷贴治疗组127个,平阳霉素(PYM)组116个。90Sr敷贴治疗组剂量300 ~ 600 cGy/次,2次/周,4次为1疗程;PYM治疗组平均每次用量3 ~ 4 mg,7 ~ 10 d后重复。结果 两组总治愈率分别为91.34 %及88.79 %;其中单纯性血管瘤90Sr敷贴治疗与PYM注射治疗两者治愈率分别为98.41 %及82.22 %,海绵状血管瘤两者治愈率分别为80.66 %及95.35 %,混合性血管瘤两者治愈率分别为87.88 %及89.29 %。结论 对于单纯性血管瘤可首先考虑90Sr敷贴治疗,而 对于海绵状血管瘤则应首先考虑PYM治疗;混合性血管瘤两种方法均可选择,但PYM注射加90Sr敷贴治疗为佳。 相似文献
8.
目的 观察平阳霉素和地塞米松联合瘤内注射治疗颌面部血管瘤的疗效.方法 采用平阳霉素和地塞米松联合颌面部血管瘤内注射治疗血管瘤52例.结果 治愈48例,基本治愈3例,好转1例,有效率100%.结论 平阳霉素和地塞米松联合瘤内注射治疗颌面部血管瘤是一种安全、可靠、简便、易行且疗效确切的治疗方法为口腔颌面部血管瘤治疗提供了新的途径. 相似文献
9.
10.
平阳霉素治疗颌面部血管瘤的临床观察 总被引:3,自引:0,他引:3
目的:观察平阳霉素对各型血管瘤的治疗效果。方法:采用:采用平阳霉素瘤内注射治疗颌面部血管瘤58例,结果:有效率达94.9%,治愈45例(77.6%),好转10例(17.2%),无效3例(5.2%),治愈组无复发病例,结论:平阳霉素治疗面部血管瘤,方法简单易行,疗程短,疗效好,毒副反应少,但该法对蔓状血管瘤治疗无效,不应用于此型血管瘤的治疗。 相似文献
11.
选择性肝动脉栓塞治疗肝海绵状血管瘤 总被引:4,自引:0,他引:4
目的 研究使用平阳霉素碘油乳剂经导管超选择插入肝动脉栓塞治疗肝海绵状血管瘤的方法和效果。方法 对32例肝海绵状血管瘤进行平阳霉素碘油乳剂经肝动脉栓塞治疗,将导管超选择插入肝血管瘤的供血动脉,以平阳霉素碘油乳剂栓塞。男14例,女18例,年龄28~62岁,平均44岁,术前均经US、CT、DSA检查确诊。结果 所有病例均成功实施了栓塞治疗;32 例中有30例分别于术后1 ~24个月进行CT或B超随访;瘤体缩小〉50%者25例,〉 30%者5例,其中B超随访肿瘤完全消失1例;1例患者肿瘤缩小不明显.30例临床有症状患者中,临床症状消失28例,明显减轻1例,总有效率96.7 %(29/30)。术中及术后无严重并发症。结论 平阳霉素碘油乳剂经肝动栓塞是治疗肝海绵状血管瘤的安全、有效的首选方法。 相似文献
12.
13.
平阳霉素治疗头颈部血管瘤的临床观察 总被引:2,自引:0,他引:2
用平阳霉素(BleomycinA5)瘤内注射治疗头颈部血管瘤18例。病变完全消退13例(72.2%),明显缩小3例(16.7%),无效2例(11.1%)。认为平阳霉素治疗血管瘤,方法简单易行,效果好,疗程短,愈后无疲痕。 相似文献
14.
目的探讨平阳霉素注射加手术切除治疗口腔颌面部海绵状血管瘤的效果。方法将8mg平阳霉素用1%利多卡因4mL充分溶解,后注射于瘤体周边或根部,以及瘤腔间缘的多处软组织内,注射时应尽可能地增加药物作用的有效面积,以注射到瘤体表面及周边组织轻微苍白肿胀为佳。每次注射的药物量应根据患者的年龄、瘤体的大小、部位等因素来决定,最多不超过8mg,每隔2wk重复注射1次,直至肿瘤消失或明显缩小。对于见效慢的或经过4次注射已明显缩小至直径lcm以下的,则采用手术切除的方法,以缩短治疗周期。结果本组共诊治23例口腔颌面部海绵状血管瘤患者中经平阳霉素局部注射治愈17例,这些被治愈的患者在治疗期间除出现轻度的胃肠道不适及发低热外,均未出现明显的不良反应,另5例显效和有效的病例最终都由手术完整切除。本组病例均经随访1-2a未见复发。结论平阳霉素注射加手术切除治疗口腔颌面部海绵状血管瘤,其方法安全、简便,效果稳定、良好,可在一般医院口腔科推广应用。 相似文献
15.
16.
Saurabh Varshney Manu Malhotra Navjot Kaur Priyanka Gairola 《Indian journal of otolaryngology and head and neck surgery》2015,67(4):417-421
Haemangiomas are relatively common in the head and neck region, but cases in the temporal bone are rare. Hemangioma of the external auditory canal (EAC) is a rare otologic entity. Up till now (till 2013), only 18 cases of hemangioma EAC have been reported in the English literature. It is commonly classified as capillary or cavernous hemangioma. According to the literature, this case represents the fourth patient with capillary hemangioma of the EAC. A 22-year-old male presented to our department with a 3 years history of right-sided aural fullness, mild pain and decreased hearing. There was no history of ear discharge, pulsatile tinnitus, vertigo and local trauma. Oto-microscopic and otoendoscopic examination revealed a smooth surface, reddish pulsatile mass arising from the right postero–superior portion of bony canal wall, which measured about 1 cm in diameter, obstructing 2/3rd of the EAC. The tympanic membrane was not seen. No facial nerve dysfunction was observed. Patient had moderate conductive hearing loss in right ear on audiology. HRCT temporal bone showed soft tissue mass involving the right EAC and middle ear. The lesion was excised via a postaural approach under general anesthesia. The tumor was a reddish, soft mass and measured 1.6 × 1.7 × 2.8 cm. The histopathologic assessment indicated a capillary hemangioma. 相似文献
17.
18.
19.
Hemangioma of the urinary bladder. 总被引:2,自引:0,他引:2
L Cheng A G Nascimento R M Neumann A Nehra J C Cheville D M Ramnani B C Leibovich D G Bostwick 《Cancer》1999,86(3):498-504
BACKGROUND: Hemangioma of the urinary bladder is rare and the long term outcome of patients is unknown. METHODS: The authors evaluated the clinical and pathologic findings in 19 patients with a vesical hemangioma. All patients were treated at the Mayo Clinic between 1932-1998 and had histologic confirmation of the diagnosis. Hemangioma was classified into cavernous, capillary, or arteriovenous types based on conventional criteria from other sites. Clinical information was obtained from chart review. The mean follow-up of the patients was 6.9 years (range, 0.3-25 years). RESULTS: The mean patient age at the time of diagnosis was 58 years (range, 19-76 years) and the male-to-female ratio was 3.7:1. Patients typically presented with macroscopic hematuria and endoscopic findings usually were nonspecific. The diagnosis of hemangioma was suspected in 3 patients (16%) prior to biopsy. There was a predilection for the posterior and lateral walls and the tumor usually was small (range, 0.2-3 cm; median, 0.7 cm) and solitary. The histologic types of hemangioma were cavernous (15 cases), capillary (2 cases), and arteriovenous (2 cases). All patients were treated with biopsy with or without fulguration, except for one patient who was treated with a partial cystectomy. No patients developed a recurrence during a mean follow-up of 6.9 years. CONCLUSIONS: Patients with hemangioma of the urinary bladder have a favorable outcome. Biopsy and fulguration are effective for hemangioma of the bladder when the lesion is small. 相似文献